Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Cancer models generated from patients before, during, or post-clinical trial are valuable resources to study patients' trial responsiveness, and could potentially serve as avatars to predict future treatment responsiveness.
Our team of clinical research coordinators offers processes for regulatory compliance to generate cancer models from clinical trial patients.
Please email email@example.com to learn more about this service.